immatics is a private biopharmaceutical company based in Tuebingen, Germany. We are focused on the discovery and development of innovative active immunotherapies against cancer. Our proprietary technology allows us to identify tumor-associated peptides (TUMAPs) that are associated with particular cancers.
http://www.immatics.info/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Sunday
LOAD TIME
immatics biotechnologies GmbH
Niels●●●●●erich
Tue●●●gen , 72076
DE
View this contact
immatics biotechnologies GmbH
Niels Emmerich
Paul-Eh●●●●●●●Str. 15
Tue●●●gen , 72076
DE
View this contact
Cronon AG Professional IT-Services
Hostmaster Strato Rechenzentrum
Emmy-No●●●●●●●Str. 10
Kar●●●uhe , Germany, 76131
DE
View this contact
Cronon AG Professional IT-Services
Hostmaster Strato Rechenzentrum
Emmy-No●●●●●●●Str. 10
Kar●●●uhe , Germany, 76131
DE
View this contact
BUY YOUR DOMAIN
Cronon AG (R199-LRMS)
WHOIS : whois.afilias.info
REFERRED :
PAGES IN
THIS WEBSITE
1
SSL
EXTERNAL LINKS
0
SITE IP
81.169.145.156
LOAD TIME
0 sec
SCORE
6.2
immatics biotechnologies - active against cancer | immatics.info Reviews
https://immatics.info
immatics is a private biopharmaceutical company based in Tuebingen, Germany. We are focused on the discovery and development of innovative active immunotherapies against cancer. Our proprietary technology allows us to identify tumor-associated peptides (TUMAPs) that are associated with particular cancers.
immatics.info
Home | Immatics
http://www.immatics.info/index.php?page=91&modid2=2013&PHPSESSID=bc8584d472a348dc3ef72f14e569c603
Immatics US, Inc. Adoptive Cellular Therapy (ACT). Adoptive Cellular Therapy (ACT). Careers – GmbH. Careers – U.S. Contact – GmbH. Contact – U.S. Immatics is a clinical-stage biopharmaceutical company dedicated to developing advanced immunotherapies that are active against cancer. Immatics is a leading cancer immunotherapy company and. Global leader in the discovery of novel targets for various types of cancer immunotherapies. In designing our immunotherapies we employ a unique and rational approach base...
TOTAL PAGES IN THIS WEBSITE
1
Blog de immathias - Immathias vous présente : ^^ les MARSEILLER ^^ - Skyrock.com
Mot de passe :. J'ai oublié mon mot de passe. Immathias vous présente : les MARSEILLER. Voilla comme promis je reparle de marseille. Mise à jour :. L'Olympique de Marseille s. Ecoute Skyrock en live. Les n 1 sont Rap and RnB. Abonne-toi à mon blog! L'Olympique de Marseille souhaite à tous ses supporters une belle et heureuse année 2010! Que lit-on sur la page qui se tourne? Est-il utile de préciser que rien n'est perdu? Inscrire une nouvelle ligne au palmarès en 2010? Ce serait la délicieuse cerise sur l...
immatics biotechnologies - active against cancer
Is a clinical-stage biopharmaceutical company dedicated to developing advanced immunotherapies that are active against cancer. Our goal is to spearhead a new era in the treatment of cancer by enabling patients to live significantly longer and better lives than with today’s therapies. Immatics biotechnologies receives $20m grant from the State of Texas for the development of immunotherapies against cancer. Immaticsâ contribution to validation of tumour mutations by mass spectrometry published in Nature.
immatics biotechnologies - active against cancer
Is a clinical-stage biopharmaceutical company dedicated to developing advanced immunotherapies that are active against cancer. Our goal is to spearhead a new era in the treatment of cancer by enabling patients to live significantly longer and better lives than with today’s therapies. Immatics biotechnologies receives $20m grant from the State of Texas for the development of immunotherapies against cancer. Immaticsâ contribution to validation of tumour mutations by mass spectrometry published in Nature.
Home - Immatics
Bringing the Power of T cells to Cancer Patients. Proprietary and Partnered Immune-oncology Programs. World Class Team and Science. Go to Bispecific TCR Molecules. Immatics has developed three innovative approaches to producing Adoptive Cell Therapies (ACT): ACTolog. These therapies are directed against targets which will transform the current landscape of tumor therapy. Bispecific T-Cell Receptor Molecules. About Bispecific T-Cell receptor molecules. MorphoSys and Immatics Biotechnologies Enter Strategi...
immatics biotechnologies - active against cancer
Is a clinical-stage biopharmaceutical company dedicated to developing advanced immunotherapies that are active against cancer. Our goal is to spearhead a new era in the treatment of cancer by enabling patients to live significantly longer and better lives than with today’s therapies. Immatics biotechnologies receives $20m grant from the State of Texas for the development of immunotherapies against cancer. Immaticsâ contribution to validation of tumour mutations by mass spectrometry published in Nature.
immatics biotechnologies - active against cancer
Is a clinical-stage biopharmaceutical company dedicated to developing advanced immunotherapies that are active against cancer. Our goal is to spearhead a new era in the treatment of cancer by enabling patients to live significantly longer and better lives than with today’s therapies. Immatics biotechnologies receives $20m grant from the State of Texas for the development of immunotherapies against cancer. Immaticsâ contribution to validation of tumour mutations by mass spectrometry published in Nature.
Home - Immatics
Bringing the Power of T cells to Cancer Patients. Proprietary and Partnered Immune-oncology Programs. World Class Team and Science. Go to Bispecific TCR Molecules. Immatics has developed three innovative approaches to producing Adoptive Cell Therapies (ACT): ACTolog. These therapies are directed against targets which will transform the current landscape of tumor therapy. Bispecific T-Cell Receptor Molecules. About Bispecific T-Cell receptor molecules. MorphoSys and Immatics Biotechnologies Enter Strategi...
immatics biotechnologies - active against cancer
Is a clinical-stage biopharmaceutical company dedicated to developing advanced immunotherapies that are active against cancer. Our goal is to spearhead a new era in the treatment of cancer by enabling patients to live significantly longer and better lives than with today’s therapies. Immatics biotechnologies receives $20m grant from the State of Texas for the development of immunotherapies against cancer. Immaticsâ contribution to validation of tumour mutations by mass spectrometry published in Nature.
immatics biotechnologies - active against cancer
Is a clinical-stage biopharmaceutical company dedicated to developing advanced immunotherapies that are active against cancer. Our goal is to spearhead a new era in the treatment of cancer by enabling patients to live significantly longer and better lives than with today’s therapies. Immatics biotechnologies receives $20m grant from the State of Texas for the development of immunotherapies against cancer. Immaticsâ contribution to validation of tumour mutations by mass spectrometry published in Nature.
immatinymonster.deviantart.com
immatinymonster (sarahhhh) - DeviantArt
Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')" class="mi". Window.devicePixelRatio*screen.width 'x' window.devicePixelRatio*screen.height) :(screen.width 'x' screen.height) ; this.removeAttribute('onclick')". Join DeviantArt for FREE. Forgot Password or Username? Deviant for 6 Years. This deviant's full pageview. Last Visit: 210 weeks ago. This is the place where you can personalize your profile! Life is...
人の役に立つアルバイト | 人に感謝されながら働くって気持ちいい！
Proudly powered by WordPress. Theme: Sixhours by Caroline Moore.
SOCIAL ENGAGEMENT